Test ID: AJPWO
Ashkenazi Jewish Mutation Analysis Panel Without Cystic Fibrosis (CF)
Method Description
Describes how the test is performed and provides a method-specific reference
A PCR-based assay using Luminex (Universal Tag/Bead-based sorting system) technology, available as an RUO (Research Use Only) kit from Tm Bioscience (Toronto, Canada), is used. The method involves a multiplex PCR amplification of target exons. Specific alleles are detected using allele-specific primer extension with detection on the Luminex instrument. This assay detects: the 84G->GG, IVS2(+1)G->A, N370S, delta55bp, V394L, D409H, L444P, and R496H mutations in Gaucher disease; the delta7.6kb, R247W, R249W, G269S IVS9(+1)G->A, 1278insTATC, and IVS12(+1)G->C mutations in Tay-Sachs disease; the 433(-2)A->G, E285A, Y231X (C->A & C->T), and A305E mutations in Canavan disease; the R696P and IVS20(+6)T->C mutations in familial dysautonomia; the 2281del6/ins7 mutation in Bloom syndrome; the 322delG and IVS4(+4)A->T mutations in Fanconi anemia; the L302P, fsP330, R496L, and deltaR608 mutations in Niemann-Pick disease types A and B; and the delta6.4kb and IVS3(-2)A->G mutations in mucolipidosis type IV. (Fulton R, McDade R, Smith P, et al: Advanced multiplexed analysis with the FlowMetrix system. Clin Chem 1997;43:1749-1756; Ye F, Li MS, Taylor JD, et al: Fluorescent microsphere-based readout technology for multiplexed human single nucleotide polymorphism analysis and bacterial identification. Hum Mutat 2001 Apr;17[4]:305-316)
Day(s) and Time(s) Test Performed
Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Tuesday; 10 a.m.


